RNAble

Developer of RNA-targeted compounds designed to modulate RNA epi transcriptomics and stabilize unstable RNA transcripts.

Health Tech & Life Sciences
Active
Seed Ness Ziona, Israel Founded 2021
Last updated 2026-07-26
Total raised
Last: Undisclosed Round 2022-01
Stage
Seed
Founded
2021
Headcount
6
HQ
Ness Ziona, Israel
Sector
Health Tech & Life Sciences

About

RNAble is a biotechnology company developing RNA-targeted compounds to modulate RNA epi transcriptomics and stabilize unstable RNA transcripts. The company's approach aims to treat specific cancers and rare genetic diseases, offering new and effective treatment options for patients.

Funding history · 1 round · — total

2021-12
Seed Undisclosed
★ Integra HoldingsRMGLOBAL Healthcare Fund Management

Headcount over time

From 4 (2022-12) to 2 (2026-03) · -2 (-50%) · 10 points · source: Finder history + radar grounding
60 2022-12 2026-03

Q&A

What is RNAble's primary focus?
RNAble is a biotechnology company developing RNA-targeted compounds to modulate RNA epi transcriptomics and stabilize unstable RNA transcripts for the treatment of specific cancers and rare genetic diseases.
Where is RNAble headquartered?
RNAble is headquartered in Ness Ziona, Israel.
What is the total amount of funding RNAble has raised to date?
RNAble has raised a total of $3,000,000 USD.
What was RNAble's most recent funding round?
RNAble's most recent funding round was a Seed round in January 2022.
Who is a co-founder of RNAble?
Rotem Karni is a Co-Founder & Advisor at RNAble.
What is the current status of RNAble's website?
RNAble's website is currently inactive, showing a suspended page as of July 3, 2026.

Team · 1

Founder · Co-Founder & Advisor
LinkedIn ↗

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
BiologicalsGenes
Target customers
Healthcare & Life SciencesHealthcareLaboratoriesProvidersLife SciencesBiotechnology
Business model
B2B

Tags

cancerrare-diseasespharmaceuticalsgenetic-disorderscancer-therapy
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitefuturx.co.il/cgi-sys/suspendedpage.cgi
LinkedInlinkedin.com/company/87382936

Identifiers & details

Founded2021
Employees (exact)6

Radar intelligence

Patents

EPO1

Publications (Crossref)

Works1

Web history (Wayback)

Domainfuturx.co.il

Certificate / subdomain footprint

Subdomains10

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516421203
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2021-06-24
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Last annual report2023
Active charges / liens0
Registry events1 — violation (1)
Registered addressרמון אילן 2 נס ציונה

Recent registry events

DateEvent
2026-06-25עדכון הפרה